Search Results 71-80 of 18141 for alopecia
... alopecia and anemia), or be deemed irreversible; Can have received Gemcitabine-based therapy in an adjuvant setting for Arm A of the trial (Gemcitabine with ...
Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn., Albert Lea, Minn ...
... Alopecia areata, Diffuse capillary malformation with overgrowth, Vulvar skin disorder, Blue rubber bleb nevus syndrome, Vascular anomaly, Vascular ...
recover to ≤ Grade 1 except alopecia or neuropathy. 9. Concurrent treatment with an investigational agent, 14 days for small molecular agents and/or 28 ...
Some conditions, including stroke or head injury, can seriously affect a person's ability to communicate. Learn about this communication disorder and its ...
- Subjects with vitiligo or alopecia - Subjects with hypothyroidism (eg, following Hashimoto's thyroiditis) stable on hormone replacement therapy or ...
... alopecia or peripheral neuropathy up to grade 2 * Patients who have had any major surgery ≤ 4 weeks prior to registration * Patients with uncontrolled ...
to Grade 1 or less except for alopecia or peripheral neuropathy - Received a cumulative dose of corticosteroids equivalent to >=70 mg of prednisone within ...
exception of alopecia, vitiligo, and protocol defined laboratory values. - Participants with Grade ≥2 neuropathy will be evaluated on a case-by-case basis
Learn about this surgery that can raise sagging brows and reduce wrinkles on the forehead. Also understand the possible risks of the procedure.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.